Home / Companies / Jazz Pharmaceuticals plc / 3 Aug 2023
Jazz Pharmaceuticals plc: meeting of 3 Aug 2023
Votes reported on Form N-PX, item by item
739 Form N-PX filers reported votes at the Jazz Pharmaceuticals plc meeting of 3 Aug 2023. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
4 nominees; 93.1% of reported votes for; 39 filers withheld from or voted against at least one nominee.
2,117 vote records from 230 filers. 12 of the 228 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
1,164 vote records from 727 filers. 42 of the 699 filers that marked the item either way voted against management. 28 filers reported this item without a management mark.
5 filers reported share counts too large to be the holding described. No share split is published for this item. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
526 vote records from 226 filers. 4 of the 224 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. No share split is published for this item. How that is decided
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
524 vote records from 224 filers. 9 of the 222 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
524 vote records from 225 filers. 9 of the 223 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
4 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Jazz Pharmaceuticals plc meeting?
739 Form N-PX filers reported votes at the meeting of 3 Aug 2023. On say-on-pay, 42 of 699 voted against management (6.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Jazz Pharmaceuticals plc on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Jazz Pharmaceuticals plc
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Jazz Pharmaceuticals plc with a meeting date within three days of 3 Aug 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.